PLN 7.45
(-0.67%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -5.77 Million PLN | -13.78% |
2022 | -4.99 Million PLN | -53.39% |
2021 | -3.25 Million PLN | -13.44% |
2020 | -2.87 Million PLN | -45.16% |
2019 | -1.97 Million PLN | -14.25% |
2018 | -1.73 Million PLN | -180.3% |
2017 | -618.03 Thousand PLN | -103.64% |
2016 | -303.48 Thousand PLN | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | -1.25 Million PLN | 4.19% |
2024 Q1 | -1.31 Million PLN | -4.04% |
2023 Q1 | -1.41 Million PLN | 18.67% |
2023 FY | -5.68 Million PLN | -13.78% |
2023 Q4 | -1.26 Million PLN | 8.15% |
2023 Q3 | -1.37 Million PLN | 15.33% |
2023 Q2 | -1.62 Million PLN | -14.69% |
2022 Q1 | -1 Million PLN | -16.4% |
2022 FY | -4.99 Million PLN | -53.39% |
2022 Q4 | -1.74 Million PLN | -46.92% |
2022 Q3 | -1.18 Million PLN | -10.54% |
2022 Q2 | -1.07 Million PLN | -7.09% |
2021 Q4 | -860 Thousand PLN | 11.43% |
2021 Q2 | -1.01 Million PLN | -149.14% |
2021 Q1 | -409 Thousand PLN | 77.39% |
2021 Q3 | -971 Thousand PLN | 4.71% |
2021 FY | -3.25 Million PLN | -13.44% |
2020 Q4 | -1.8 Million PLN | -281.52% |
2020 Q1 | -436.31 Thousand PLN | 52.61% |
2020 Q2 | -154.21 Thousand PLN | 64.66% |
2020 Q3 | -474.21 Thousand PLN | -207.51% |
2020 FY | -2.87 Million PLN | -45.16% |
2019 Q2 | -328.66 Thousand PLN | -39.25% |
2019 FY | -1.97 Million PLN | -14.25% |
2019 Q4 | -920.69 Thousand PLN | -74.18% |
2019 Q3 | -528.59 Thousand PLN | -60.83% |
2019 Q1 | -236.02 Thousand PLN | 68.89% |
2018 Q1 | -257.3 Thousand PLN | 7.2% |
2018 Q4 | -758.76 Thousand PLN | -159.75% |
2018 Q2 | -424.52 Thousand PLN | -64.99% |
2018 FY | -1.73 Million PLN | -180.3% |
2018 Q3 | -292.12 Thousand PLN | 31.19% |
2017 Q2 | -154.85 Thousand PLN | 0.0% |
2017 FY | -618.03 Thousand PLN | -103.64% |
2017 Q3 | -133.37 Thousand PLN | 13.87% |
2017 Q4 | -277.26 Thousand PLN | -107.88% |
2016 FY | -303.48 Thousand PLN | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Adiuvo Investments S.A. | -5.07 Million PLN | -13.939% |
Genomtec S.A. | -8.72 Million PLN | 33.78% |
Medicalgorithmics S.A. | 433 Thousand PLN | 1434.642% |
Synektik Spólka Akcyjna | 107.81 Million PLN | 105.36% |